Cargando…

A Branched and Double Alpha-Gal-Bearing Synthetic Neoglycoprotein as a Biomarker for Chagas Disease

Chagas disease (CD) is caused by the parasite Trypanosoma cruzi and affects 6–7 million people worldwide. The diagnosis is still challenging, due to extensive parasite diversity encompassing seven genotypes (TcI-VI and Tcbat) with diverse ecoepidemiological, biological, and pathological traits. Chem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montoya, Alba L., Carvajal, Elisa G., Ortega-Rodriguez, Uriel, Estevao, Igor L., Ashmus, Roger A., Jankuru, Sohan R., Portillo, Susana, Ellis, Cameron C., Knight, Colin D., Alonso-Padilla, Julio, Izquierdo, Luis, Pinazo, Maria-Jesus, Gascon, Joaquim, Suarez, Veronica, Watts, Douglas M., Malo, Iliana R., Ramsey, Janine M., Alarcón De Noya, Belkisyolé, Noya, Oscar, Almeida, Igor C., Michael, Katja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457857/ https://www.ncbi.nlm.nih.gov/pubmed/36080480 http://dx.doi.org/10.3390/molecules27175714

Ejemplares similares

Specific Recognition of β-Galactofuranose-Containing Glycans of Synthetic Neoglycoproteins by Sera of Chronic Chagas Disease Patients
por: Montoya, Alba L., et al.
Publicado: (2022)

Update on oral Chagas disease outbreaks in Venezuela: epidemiological, clinical and diagnostic approaches
por: de Noya, Belkisyolé Alarcón, et al.
Publicado: (2015)

Development of Diagnostics for Chagas Disease: Where Should We Put Our Limited Resources?
por: Picado, Albert, et al.
Publicado: (2017)

ECG Manifestations of the Biggest Outbreak of Chagas Disease due to Oral Infection in Latin-America
por: Marques, Juan, et al.
Publicado: (2013)

Characterization and Follow-Up of Trypanosoma cruzi Natural Populations Refractory to Etiological Chemotherapy in Oral Chagas Disease Patients
por: Muñoz-Calderón, Arturo, et al.
Publicado: (2021)

An α-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania major
por: Iniguez, Eva, et al.
Publicado: (2017)

Ten years follow-up of the largest oral Chagas disease outbreak: Cardiological prospective cohort study
por: Ruiz-Guevara, Raiza, et al.
Publicado: (2023)

Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus
por: Alonso-Padilla, Julio, et al.
Publicado: (2020)

Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteins
por: Viana, Sayonara M., et al.
Publicado: (2022)

Reversed Immunoglycomics Identifies α-Galactosyl-Bearing Glycotopes Specific for Leishmania major Infection
por: Montoya, Alba L., et al.
Publicado: (2021)

Description of an oral Chagas disease outbreak in Venezuela, including a vertically transmitted case
por: de Noya, Belkisyolé Alarcón, et al.
Publicado: (2017)

Trypanosoma cruzi: Time for International Recognition as a Foodborne Parasite
por: Robertson, Lucy J., et al.
Publicado: (2016)

Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives
por: Pinazo, Maria-Jesus, et al.
Publicado: (2015)

Orally-transmitted Chagas disease: Epidemiological, clinical, serological and molecular outcomes of a school microepidemic in Chichiriviche de la Costa, Venezuela
por: Alarcón de Noya, Belkisyolé, et al.
Publicado: (2016)

A prophylactic α-Gal-based glycovaccine effectively protects against murine acute Chagas disease
por: Portillo, Susana, et al.
Publicado: (2019)

Loop-Mediated Isothermal Amplification of Trypanosoma cruzi DNA for Point-of-Care Follow-Up of Anti-Parasitic Treatment of Chagas Disease
por: Muñoz-Calderón, Arturo A., et al.
Publicado: (2022)

Immunoinformatics and Pepscan strategies on the path of a peptide-based serological diagnosis of COVID19
por: Lorenzo, Maria A., et al.
Publicado: (2021)

Molecular Epidemiologic Source Tracking of Orally Transmitted Chagas Disease, Venezuela
por: Segovia, Maikell, et al.
Publicado: (2013)

In silico Design of an Epitope-Based Vaccine Ensemble for Chagas Disease
por: Michel-Todó, Lucas, et al.
Publicado: (2019)

Shotgun scanning glycomutagenesis: A simple and efficient strategy for constructing and characterizing neoglycoproteins
por: Li, Mingji, et al.
Publicado: (2021)

Altered Hypercoagulability Factors in Patients with Chronic Chagas Disease: Potential Biomarkers of Therapeutic Response
por: Pinazo, Maria-Jesus, et al.
Publicado: (2016)

Fasciola hepatica Immune Regulates CD11c(+) Cells by Interacting with the Macrophage Gal/GalNAc Lectin
por: Rodríguez, Ernesto, et al.
Publicado: (2017)

Corrigendum: In silico Design of an Epitope-Based Vaccine Ensemble for Chagas Disease
por: Michel-Todó, Lucas, et al.
Publicado: (2020)

Immunosuppression and Chagas Disease: A Management Challenge
por: Pinazo, María-Jesús, et al.
Publicado: (2013)

Facile Preparation of Fluorescent Neoglycoproteins Using p-Nitrophenyl Anthranilate as a Heterobifunctional Linker
por: Luyai, Anthony, et al.
Publicado: (2009)

Fluorescent Neoglycoprotein Gold Nanoclusters: Synthesis and Applications in Plant Lectin Sensing and Cell Imaging
por: Brzezicka, Katarzyna Alicja, et al.
Publicado: (2018)

Rapid Evaluation of Antibacterial Carbohydrates on a Microfluidic Chip Integrated with the Impedimetric Neoglycoprotein Biosensor
por: Ji, Haijie, et al.
Publicado: (2023)

Amaryllidaceae plants: a potential natural resource for the treatment of Chagas disease
por: Martínez-Peinado, Nieves, et al.
Publicado: (2021)

A strategy for scaling up access to comprehensive care in adults with Chagas disease in endemic countries: The Bolivian Chagas Platform
por: Pinazo, Maria-Jesus, et al.
Publicado: (2017)

Multi-criteria decision analysis approach for strategy scale-up with application to Chagas disease management in Bolivia
por: Pinazo, Maria-Jesus, et al.
Publicado: (2021)

Genome of the fatal tapeworm Sparganum proliferum uncovers mechanisms for cryptic life cycle and aberrant larval proliferation
por: Kikuchi, Taisei, et al.
Publicado: (2021)

A Neoglycoprotein-Immobilized Fluorescent Magnetic Bead Suspension Multiplex Array for Galectin-Binding Studies
por: Zhang, Libo, et al.
Publicado: (2021)

Trypanosoma cruzi loop-mediated isothermal amplification (Trypanosoma cruzi Loopamp) kit for detection of congenital, acute and Chagas disease reactivation
por: Besuschio, Susana A., et al.
Publicado: (2020)

Defects in immune response to Toxoplasma gondii are associated with enhanced HIV-1-related neurocognitive impairment in co-infected patients
por: Escobar-Guevara, Edwin Eliel, et al.
Publicado: (2023)

Plasma-Derived Extracellular Vesicles as Potential Biomarkers in Heart Transplant Patient with Chronic Chagas Disease
por: Cortes-Serra, Nuria, et al.
Publicado: (2020)

Results and evaluation of the expansion of a model of comprehensive care for Chagas disease within the National Health System: The Bolivian Chagas network
por: Pinazo, Maria-Jesus, et al.
Publicado: (2022)

Characterization of digestive disorders of patients with chronic Chagas disease in Cochabamba, Bolivia
por: Pinto, Jimy-Jose, et al.
Publicado: (2019)

Strengthening the Bolivian pharmacovigilance system: New surveillance strategies to improve care for Chagas disease and tuberculosis
por: Cortes-Serra, Nuria, et al.
Publicado: (2020)

Rapid diagnostic tests duo as alternative to conventional serological assays for conclusive Chagas disease diagnosis
por: Egüez, Karina E., et al.
Publicado: (2017)

Synthesis and Photoreactivity of 7-Nitroindoline-S-thiocarbamates
por: Baily, Philip T., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3p67htpmm0m7c6ejtlcn4tigt2